Trial · NCT03193866
Outcomes16
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 16 of 16
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Confirmed Disease Progression in Patients With Expanded Disability Status Scale (EDSS) <2.5 at Baseline | 3 years | First line and Second line reported in separate rows | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Confirmed Disease Progression in Patients With EDSS ≥2.5 at Baseline | 3 years | First line and Second line reported in separate rows | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Disease-related Impact on Daily Life, Physical | 3 years | First line and Second line reported in separate rows | units on a scale | MEAN |
| PRIMARY | Disease-related Impact on Daily Life, Psychological | 3 years | First line and Second line reported in separate rows | units on a scale | MEAN |
| SECONDARY | Annualized Relapse Rate | 3 years | First line and Second line reported in separate rows | percentage of relapses | MEAN |
| SECONDARY | Remaining on Drug | 3 years | First line and Second line reported in separate rows | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Increase in EDSS | 3 years | First line and Second line reported in separate rows | units on a scale | MEAN |
| SECONDARY | Proportion of Patients With at Least 1 Step Increase in EDSS | 3 years | First line and Second line reported in separate rows | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Proportion of Patients With No Evidence of Disease Activity (NEDA) -2 | 3 years | First line and Second line reported in separate rows | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Proportion of Patients With NEDA-3 | 3 years | First line and Second line reported in separate rows | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Quality of Life Assessments | 3 years | First line and Second line reported in separate rows | units on a scale | MEAN |
| SECONDARY | Fatigue | 3 years | First line and Second line reported in separate rows | units on a scale | MEAN |
| SECONDARY | Treatment Satisfaction | 3 years | First line and Second line reported in separate rows | units on a scale | MEAN |
| SECONDARY | Rate of Serious Infections | 3 years | First line and Second line reported in separate rows | infections per 1000 person-years | NUMBER |
| SECONDARY | Rate of Major Adverse Cardiovascular Events (MACE) | 3 years | First line and Second line reported in separate rows | MACE per 1000 person-years | NUMBER |
| SECONDARY | Rate of Invasive Cancer | 3 years | First line and Second line reported in separate rows | invasive cancer per 1000 person-years | NUMBER |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03193866/outcomes